Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
North West Genomics Laboratory Hub, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Otol Neurotol. 2020 Apr;41(4):431-437. doi: 10.1097/MAO.0000000000002588.
USH2A-related disorders are characterised by genetic and phenotypic heterogeneity, and are associated with a spectrum of sensory deficits, ranging from deaf blindness to blindness with normal hearing. It has been previously proposed that the presence of specific USH2A alleles can be predictive of unaffected hearing. This study reports the clinical and genetic findings in a group of patients with USH2A-related disease and evaluates the validity of the allelic hierarchy model.
USH2A variants from 27 adults with syndromic and nonsyndromic USH2A-related disease were analyzed according to a previously reported model of allelic hierarchy. The analysis was replicated on genotype-phenotype correlation information from 197 individuals previously reported in 2 external datasets.
Genotype-phenotype correlations in USH2A-related disease.
A valid allelic hierarchy model was observed in 93% of individuals with nonsyndromic USH2A-retinopathy (n = 14/15) and in 100% of patients with classic Usher syndrome type IIa (n = 8/8). Furthermore, when two large external cohorts of cases were combined, the allelic hierarchy model was valid across 85.7% (n = 78/91) of individuals with nonsyndromic USH2A-retinopathy and 95% (n = 123/129) of individuals with classic Usher syndrome type II (p = 0.012, χ test). Notably, analysis of all three patient datasets revealed that USH2A protein truncating variants were reported most frequently in individuals with hearing loss.
Genetic testing results in individuals suspected to have an USH2A-related disorder have the potential to facilitate personalized audiological surveillance and rehabilitation pathways.
USH2A 相关疾病的特征是遗传和表型异质性,并伴有一系列感觉缺陷,从耳聋失明到听力正常的失明。先前有研究提出,特定 USH2A 等位基因的存在可以预测听力不受影响。本研究报告了一组 USH2A 相关疾病患者的临床和遗传发现,并评估了等位基因层次模型的有效性。
根据先前报道的等位基因层次模型,对 27 名有综合征和非综合征 USH2A 相关疾病的成人的 USH2A 变体进行分析。对先前在 2 个外部数据集报告的 197 名个体的基因型-表型相关性信息进行了复制分析。
USH2A 相关疾病的基因型-表型相关性。
在 93%的非综合征性 USH2A-视网膜病变患者(n=14/15)和 100%的经典 Usher 综合征 IIa 型患者(n=8/8)中观察到有效的等位基因层次模型。此外,当将两个大型外部病例队列合并时,等位基因层次模型在 85.7%(n=78/91)的非综合征性 USH2A-视网膜病变患者和 95%(n=123/129)的经典 Usher 综合征 II 型患者中均有效(p=0.012,卡方检验)。值得注意的是,对所有三个患者数据集的分析表明,在有听力损失的个体中,USH2A 蛋白截断变异体的报道最为频繁。
对疑似 USH2A 相关疾病的个体进行基因检测,有可能促进个性化的听力监测和康复途径。